MEG3 and ovarian carcinoma: However, miR-26a has been shown to promote proliferation and tumorigenesis of ovarian cancer cells through the targeting of ER-α, suggesting a putative different relationship between MEG3 and miR-26a in ovarian cancer that remains to be investigated [97].